Public Beta

The countdown model and news pipeline are under development. Scores are model inputs and may change as evidence is reviewed.

Latest research

Field
Immune Engineering & Cancer Control
Date
Evidence
Evidence E

Registry Lists an FES PET/CT Study for ER-Positive Breast Cancer

ClinicalTrials.gov posted an observational registration that is enrolling by invitation. No results are posted.

The signal

Study design
Trial registration and research plan. Observational study. Overall status: enrolling by invitation. No results posted.
Population / model
Participants named in the registry record. The record does not state a sample size.
Intervention
FES PET/CT imaging
Outcomes
No results are posted.
Limitations
This is a first public registration, not a completed study. Enrolling by invitation is not an open call for participants. No treatment effect is reported.
Result status
Trial registration and research plan. No results posted.

What happened

Registry record NCT07859046 is an observational study of FES PET/CT in estrogen receptor-positive breast cancer. The record says its purpose is to see how the scans can help doctors diagnose that cancer, plan treatment, and check treatment response. Participants undergo the scans as part of regular cancer care or study procedures. The overall status is enrolling by invitation.

Why it matters

A first public registration shows what the study plans to ask. It does not show whether the imaging changes care.

Reality check

No results are posted. Enrolling by invitation is not an open call for participants, and the registration is not a completed study or an established treatment.

Does this move the countdown?

NO — NOT YET

The LEV model is re-evaluated about twice a year, or sooner after an extraordinary event. A typical research article does not change the countdown.

Source

ClinicalTrials.gov

Read the primary source →

日本語で読む